Article
Comparison of clinical outcomes of several risk stratification tools in newly diagnosed AML patients: A real-world evidence in our current therapeutic era.
Cancer medicine - 1 Mar 2024
Iat Alexandre, Loschi Michael, Benachour Sami, Calleja Anne, Chiche Edmond, Sudaka Isabelle, Aquaronne Danièle, Ferrero Corinne, Fenwarth Laurène, Marceau Alice, Fournier Elise, Dadone-Montaudie Berengere, Cluzeau Thomas
Abstract excerpt
BACKGROUND OF THE STUDY: AML classification tools have been developed to stratify the risk at AML diagnosis. There is a need to evaluate these tools in the current therapeutic era. COHORT CHARACTERISTICS: In this retrospective study, we compared five classifiers: ELN 2017, ELN 2022, ALFA classifier, Papaemmanuil et al. classifier, and Lindsley et al. classifier, in a real-life cohort of 281 patients newly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.